FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

CJC-1295 (no DAC) vial

GHRH Analogue

CJC-1295 (no DAC)

  • Modified GRF (1-29)
  • Mod-GRF(1-29)
  • CJC-1295 without DAC

A tetra-substituted analogue of GRF(1-29) (Modified GRF 1-29). Studied as a short-acting GHRH analogue that amplifies pulsatile growth-hormone release — the "no DAC" form, without the albumin-binding drug-affinity complex.

Dosage
Quantity
$199.00
View CoA
or check out in one tap
Ships in 24-48h
Free shipment protection
Overnight available
We accept Apple Pay Visa
Free shipping on orders over $150
Damage protection
Secure checkout 256-bit SSL

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

Latest

99.0%

Purity

Variant CJC-1295 (no DAC)
Lot # SAMPLE-PENDING
Labeled
Actual
Tested Pending

Compound Information

Technical specifications

Molecular Profile

What Is CJC-1295 (no DAC)?

Type Modified GRF(1-29) analogue (29 aa)
CAS Number 446036-97-1
Molecular Weight 3367.9 g/mol
Amino Acids 29 (D-Ala at position 2)
Formula C152H252N44O42
PubChem Database
Storage Requirements

Stability Information

  • Lyophilized — long-term stable
  • Protect from light
  • Reconstitute with bacteriostatic water
Lyophilized (powder) −20°C · stable 24+ months
Reconstituted 2–8°C · use within 30 days
Handling Avoid repeated freeze-thaw

Sources & References

Peer-reviewed research

Endocrinology

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog

2005 · DOI: 10.1210/en.2004-1286

Jetté L et al.

View Source

J Clin Endocrinol Metab

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

2006 · DOI: 10.1210/jc.2005-1536

Teichman SL et al.

View Source

J Clin Endocrinol Metab

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog

2006 · DOI: 10.1210/jc.2006-1702

Ionescu M, Frohman LA

View Source

Am J Physiol Endocrinol Metab

Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse

2006 · DOI: 10.1152/ajpendo.00201.2006

Alba M et al.

View Source

Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

All the research peptides you need, with the peace of mind and research community at your fingertips.

Shop Now

Research updates from SFSC

Subscribe for catalog updates, new research compounds, and quality documentation news

For researchers and labs. No spam, unsubscribe anytime.

Subscribed — coming soon!

Scroll to Top